Personal-Genetics Firm Denies Pursuit of 'Designer Babies'

Posted: October 2, 2013 at 9:44 pm

23andMe says it has no plans to pursue concepts discussed in its patent for a method to predict a baby's traits based on its parents' DNA

By Ewen Callaway and Nature News Blog

Image: 23andMe

Showcasing more than fifty of the most provocative, original, and significant online essays from 2011, The Best Science Writing Online 2012 will change the way...

Read More

Originally posted on the Nature news blog

The consumer genetics firm 23andMe was last week awarded a US patent for a method to predict a babys traits based on its parents DNA, the company announced.

23andMe, which is based inMountain View, California, says that the patent relates to its Family Traits Inheritance Calculator, which offers an engaging way for you and your partner to see what kind of traits your child might inherit from you and has been available to customers since 2009. Yet the patent (PDF here), which was filed more than 5 years ago, includes language that mentions other applications of the method, including for the screening of sperm and ova to be used for in vitro fertilization. The patent mentions the potential to screen would-be babies for traits such as eye color, disease risk, height and gender.

The company says that it included such language when it filed the patent because it saw the potential for the tool to be used in fertility clinics. But much has evolved in that time, including 23andMes strategic focus. The company never pursued the concepts discussed in the patent beyond our Family Traits Inheritance Calculator, nor do we have any plans to do so, it says.

Go here to read the rest:
Personal-Genetics Firm Denies Pursuit of 'Designer Babies'

Related Posts

Comments are closed.

Archives